Immune checkpoint analysis in ear cancer

Head Face Med. 2023 Nov 6;19(1):48. doi: 10.1186/s13005-023-00395-w.

Abstract

Background: Among cutaneous squamous cell carcinomas, the ear (ecSCC) is one of the most common sites. Loco regional lymph node metastasis is found in six to eleven percent of cases, corresponding to increased metastasis compared to other sites. The aim of this study was to test the markers PD-L1, PD-1, CD4, CD8, and FoxP3 for suitability as prognostic predictive markers.

Methods: Sixty-four patients with ecSCC were included in this study. The expression of immunohistochemical markers (PD-L1, PD-1, CD4, CD8, FOXP3) was correlated with retrospective clinic pathological parameters (lymph node metastasis, distant metastasis, lymph node metastasis during follow-up, disease progression, disease-specific death).

Results: There was a correlation between increased disease specific death and a weak Foxp3 (p = 0.003) or reduced CD8 (p = 0.04). A PD-L1 expression > 1% was found in 39.1% of patients.

Conclusion: The investigated markers (CD4, CD8, FoxP3, PD-1, PD-L1) seem overall rather inappropriate for prognostic evaluation in ecSCC. Only the correlation of disease specific death with CD8 or FoxP3 seems to be worth testing in larger collectives.

MeSH terms

  • B7-H1 Antigen* / analysis
  • B7-H1 Antigen* / metabolism
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / metabolism
  • Ear Neoplasms*
  • Forkhead Transcription Factors / analysis
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Lymphatic Metastasis
  • Prognosis
  • Programmed Cell Death 1 Receptor
  • Retrospective Studies

Substances

  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor
  • Forkhead Transcription Factors
  • Biomarkers, Tumor